Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 35,137 | 3,637 | 391,000 | 117,432 | 45,653 |
| Depreciation Amortization | 5,647 | 2,540 | 6,336 | 4,082 | 2,234 |
| Income taxes - deferred | 9,679 | -94 | -249,879 | N/A | N/A |
| Accounts receivable | -29,188 | -13,893 | -22,718 | -17,111 | -8,766 |
| Accounts payable and accrued liabilities | 33,666 | 1,343 | -5,289 | 5,555 | 3,905 |
| Other Working Capital | 52,661 | 13,200 | -89,756 | -1,847 | 10,672 |
| Other Operating Activity | 27,160 | 27,248 | 80,142 | 50,456 | 30,581 |
| Operating Cash Flow | $134,762 | $33,981 | $109,836 | $158,567 | $84,279 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 68,053 | 71,493 | -692,565 | -534,951 | -68,208 |
| PPE Investments | -10,301 | -5,212 | -4,690 | -685 | -297 |
| Sale Of Investment | N/A | N/A | 493,529 | 387,779 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -98,838 | N/A |
| Other Investing Activity | 0 | 0 | -98,838 | -98,838 | -98,838 |
| Investing Cash Flow | $57,752 | $66,281 | $-302,564 | $-246,695 | $-167,343 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,725 | 4,231 | 49,883 | 27,217 | 17,794 |
| Financing Cash Flow | $14,725 | $4,231 | $49,883 | $27,217 | $17,794 |
| Exchange Rate Effect | 52 | 25 | 26 | 19 | 19 |
| Beginning Cash Position | 185,540 | 185,540 | 328,359 | 328,359 | 328,359 |
| End Cash Position | 392,831 | 290,058 | 185,540 | 267,467 | 263,108 |
| Net Cash Flow | $207,291 | $104,518 | $-142,819 | $-60,892 | $-65,251 |
| Free Cash Flow | |||||
| Operating Cash Flow | 134,762 | 33,981 | 109,836 | 158,567 | 84,279 |
| Capital Expenditure | -10,301 | -5,212 | -4,690 | -685 | -297 |
| Free Cash Flow | 124,461 | 28,769 | 105,146 | 157,882 | 83,982 |